Data / Form D filings / Ultivue, Inc.
Ultivue, Inc.: Form D filings
Ultivue, Inc., a biotechnology company in Cambridge, MA, filed 5 Form D notices with the SEC between 2015 and 2024. The latest, on July 25, 2024, reports $3.3 million sold of a $15 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 763D CONCORD AVE., Cambridge, MA, 02138
- Phone
- (877) 858-4883
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1651511
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 25, 2024 | New notice | $14,999,962 | $3,324,270 | $11,675,692 | 5 | Jul 11, 2024 | sec.gov |
| Jun 28, 2019 | New notice | $26,502,993 | $26,502,993 | 14 | Jun 13, 2019 | sec.gov | |
| Feb 1, 2018 | Amendment | $20,499,996 | $20,249,996 | $250,000 | 11 | Jul 6, 2017 | sec.gov |
| Jul 21, 2017 | New notice | $13,999,997 | $10,101,968 | $3,898,029 | 6 | Jul 6, 2017 | sec.gov |
| Aug 21, 2015 | New notice | $5,150,000 | $5,150,000 | 6 | Aug 7, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrea Jackson | Director | |
| Keith Crandell | Director | |
| Peng Yin | Director | |
| Fenel Eloi | Director | |
| Robert Carson | Executive Officer, Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 22, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Ultivue, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.